J Psychother Pract Res DSM-IV-TR Content Alerting
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hellerstein, D. J.
Right arrow Articles by Winston, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hellerstein, D. J.
Right arrow Articles by Winston, A.
Related Collections
Right arrow Other Psychotherapy
J Psychother Pract Res 10:93-103, April 2001
© 2001 American Psychiatric Association


Regular Article

Adding Group Psychotherapy to Medication Treatment in Dysthymia

A Randomized Prospective Pilot Study

David J. Hellerstein, M.D., Suzanne A. S. Little, Ph.D., Lisa Wallner Samstag, Ph.D., Sarai Batchelder, Ph.D., J. Christopher Muran, Ph.D., Michael Fedak, M.D., David Kreditor, M.D., Ph.D., Richard N. Rosenthal, M.D. and Arnold Winston, M.D.

Received August 11, 1999; revised November 17, 2000; accepted January 11, 2001. From the Department of Psychiatry, Beth Israel Medical Center, and New York State Psychiatric Institute, New York. Address correspondence to Dr. Hellerstein, New York State Psychiatric Institute, Unit 101, 1051 Riverside Drive, New York, NY 10032.

Patients with dysthymia have been shown to respond to treatment with antidepressant medications, and to some degree to psychotherapy. Even patients successfully treated with medication often have residual symptoms and impaired psychosocial functioning. The authors describe a prospective randomized 36-week study of dysthymic patients, comparing continued treatment with antidepressant medication (fluoxetine) alone and medication with the addition of group therapy treatment. After an 8-week trial of fluoxetine, medication-responsive subjects were randomly assigned to receive either continued medication only or medication plus 16 sessions of manualized group psychotherapy. Results provide preliminary evidence that group therapy may provide additional benefit to medication-responding dysthymic patients, particularly in interpersonal and psychosocial functioning.

Key Words: Dysthymia • Group Therapy • Pharmacotherapy




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
S. Pampallona, P. Bollini, G. Tibaldi, B. Kupelnick, and C. Munizza
Combined Pharmacotherapy and Psychological Treatment for Depression: A Systematic Review
Arch Gen Psychiatry, July 1, 2004; 61(7): 714 - 719.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2001 American Psychiatric Association